ClearPoint Neuro Inc.

NASDAQ: CLPT · Real-Time Price · USD
11.66
-0.02 (-0.17%)
At close: Aug 15, 2025, 12:28 PM

ClearPoint Neuro Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
9.21M 8.48M 7.77M 8.12M 7.86M 7.64M 6.81M 5.76M 5.95M 5.43M 5.17M 5.15M 5.2M 5.03M 4.28M 4.57M 3.41M 4.03M
Cost of Revenue
3.66M 3.35M 3.01M 3.27M 2.87M 3.11M 2.8M 2.49M 2.82M 2.23M 1.86M 1.43M 1.94M 1.78M 993K 1.49M 1.12M 1.42M
Gross Profit
5.56M 5.13M 4.76M 4.85M 4.99M 4.53M 4.01M 3.27M 3.13M 3.2M 3.32M 3.71M 3.26M 3.25M 3.29M 3.09M 2.29M 2.61M
Operating Income
-5.68M -6.16M -5.6M -5.17M -4.74M -4.23M -4.71M -4.9M -7.13M -5.71M -4.47M -3.79M -4.2M -3.86M -3.98M -3.8M -3.41M -2.18M
Interest Income
n/a 151K 226K 209K 326K 111K 91K 100K 81K 114K 84K 32K n/a n/a n/a n/a n/a n/a
Pretax Income
-5.81M -6.01M -5.39M -4.97M -4.41M -4.15M -4.62M -4.81M -7.05M -5.61M -4.38M -3.79M -4.3M -3.96M -4.15M -3.98M -3.74M -2.54M
Net Income
-5.84M -6.03M -5.39M -4.97M -4.41M -4.15M -4.62M -4.81M -7.05M -5.39M -4.3M -3.78M -4.4M -4.05M -4.15M -3.98M -3.74M -2.54M
Selling & General & Admin
7.41M 7.92M 7.03M 6.7M 6.61M 6.13M 6.07M 5.74M 6.65M 5.89M 4.16M 5.05M 5.18M 4.58M 4.54M 4.26M 3.57M 3.23M
Research & Development
3.83M 3.38M 3.33M 3.31M 3.12M 2.63M 2.65M 2.43M 3.6M 3.02M 3.62M 2.45M 2.28M 2.53M 2.73M 2.63M 2.12M 1.56M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a -2K -11K n/a -25K -8K 11K -3K 62K n/a -25K
Operating Expenses
11.24M 11.29M 10.37M 10.02M 9.73M 8.76M 8.72M 8.17M 10.26M 8.91M 7.79M 7.51M 7.46M 7.11M 7.27M 6.89M 5.7M 4.79M
Interest Expense
80K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 91K 106K 164K 238K 240K 332K
Selling & Marketing Expenses
4.02M 3.83M 3.81M 3.55M 3.83M 3.29M 3.35M 2.84M 3.47M 2.93M 3.19M 2.14M 2.19M 1.84M 1.84M 1.83M 1.59M 1.57M
Cost & Expenses
14.89M 14.65M 13.38M 13.29M 12.6M 11.87M 11.52M 10.66M 13.08M 11.14M 9.64M 8.94M 9.4M 8.89M 8.26M 8.38M 6.82M 6.21M
Income Tax Expense
25K -18K n/a n/a n/a 15K n/a n/a n/a -217K -84K -7K 99K 95K n/a n/a -37K n/a
Shares Outstanding (Basic)
28.26M 27.72M 27.03M 27.59M 27.47M 25.45M 24.63M 24.63M 24.58M 24.58M 24.53M 24.5M 23.99M 23.68M 22.52M 22.11M 21.52M 18.85M
Shares Outstanding (Diluted)
28.26M 27.72M 27.03M 27.59M 27.47M 25.45M 24.63M 24.63M 24.58M 24.58M 24.53M 24.5M 23.99M 23.68M 22.52M 22.52M 21.52M 18.85M
EPS (Basic)
-0.21 -0.22 -0.2 -0.18 -0.16 -0.16 -0.19 -0.2 -0.29 -0.22 -0.18 -0.15 -0.18 -0.17 -0.18 -0.18 -0.17 -0.13
EPS (Diluted)
-0.21 -0.22 -0.2 -0.18 -0.16 -0.16 -0.19 -0.2 -0.29 -0.22 -0.18 -0.15 -0.18 -0.17 -0.18 -0.18 -0.17 -0.13
EBITDA
-5.68M -6.16M -5.13M -4.68M -4.28M -3.76M -4.28M -4.47M -6.71M -5.44M -4.23M -3.63M -3.98M -3.63M -3.81M -3.56M -3.32M -2.06M
EBIT
-5.73M -6.01M -5.6M -5.17M -4.74M -4.23M -4.71M -4.9M -7.13M -5.71M -4.47M -3.79M -4.2M -3.86M -3.98M -3.74M -3.5M -2.21M
Depreciation & Amortization
n/a 334K 471K 495K 463K 474K 424K 423K 339K 271K 153K 170K 235K 219K 179K 184K 181K 148K